Literature DB >> 7352712

Treatment of tularemia, including pulmonary tularemia, with gentamicin.

W L Mason, H T Eigelsbach, S F Little, J H Bates.   

Abstract

An alternative to streptomycin for treatment of possible tularemia would be useful on occasions when a patient develops a perplexing pneumonia that does not respond to initial treatment. In geographic areas where tularemia is endemic, an antimicrobial drug that is bactericidal for Francisella tularensis and is also effective against a spectrum of common pulmonary pathogens, including the Enterobacteriaceae and most strains of Pseudomonas aeruginosa, would be desirable. The purposes of this report are (1) to describe observations regarding the in vitro susceptibility of Francisella tularensis to streptomycin, kanamycin, and gentamicin; (2) to describe in vivo efficacy of these drugs in mouse tularemia; (3) to describe the results in 10 patients with tularemia treated with gentamicin. Gentamicin was bactericidal for Francisella tularensis in vitro, was effective in mouse tularemia when given in large doses, and was effective in humans when given in the standard recommended dose.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7352712     DOI: 10.1164/arrd.1980.121.1.39

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.

Authors:  Michael A Pammit; Varija N Budhavarapu; Erin K Raulie; Karl E Klose; Judy M Teale; Bernard P Arulanandam
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Tularemia.

Authors:  K K Carlson
Journal:  Can Fam Physician       Date:  1982-03       Impact factor: 3.275

4.  Tularemia from domestic cats.

Authors:  W C Liles; R J Burger
Journal:  West J Med       Date:  1993-06

5.  "Muskrat fever": two outbreaks of tularemia near Montreal.

Authors:  L Ford-Jones; G Delage; K R Powell; G A Ahronheim; E Rousseau; F Gosselin
Journal:  Can Med Assoc J       Date:  1982-08-15       Impact factor: 8.262

6.  Bactericidal activities of antibiotics against intracellular Francisella tularensis.

Authors:  M Maurin; N F Mersali; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

7.  Azithromycin effectiveness against intracellular infections of Francisella.

Authors:  Saira Ahmad; Lyman Hunter; Aiping Qin; Barbara J Mann; Monique L van Hoek
Journal:  BMC Microbiol       Date:  2010-04-23       Impact factor: 3.605

8.  Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.

Authors:  Damiana Chiavolini; Joseph Alroy; Carol A King; Peter Jorth; Susan Weir; Guillermo Madico; John R Murphy; Lee M Wetzler
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

9.  A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia.

Authors:  Charlotte A Hall; Helen C Flick-Smith; Sarah V Harding; Helen S Atkins; Richard W Titball
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

10.  Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth.

Authors:  C N Baker; D G Hollis; C Thornsberry
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.